Trials / Sponsors / OncoVerity, Inc.
OncoVerity, Inc.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed Leukemia, Myeloid, Acute | Phase 2 | 2024-07-22 |
| Completed | A Study of Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia o Leukemia, Myeloid, Acute | Phase 1 | 2020-03-25 |
| Active Not Recruiting | Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukem Leukemia, Myeloid, Acute | Phase 1 | 2019-12-23 |
| Active Not Recruiting | A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are No Leukemia, Myeloid, Acute | Phase 2 | 2019-07-29 |
| Completed | A Study of ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemi Leukemia, Myeloid, Acute, Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2016-12-01 |
| Completed | A Study of ARGX-110 in Participants With Advanced Malignancies Neoplasms | Phase 1 / Phase 2 | 2013-02-27 |